155 related articles for article (PubMed ID: 16177573)
1. p16INK4a as a second effector of the telomere damage pathway.
Jacobs JJ; de Lange T
Cell Cycle; 2005 Oct; 4(10):1364-8. PubMed ID: 16177573
[TBL] [Abstract][Full Text] [Related]
2. Significant role for p16INK4a in p53-independent telomere-directed senescence.
Jacobs JJ; de Lange T
Curr Biol; 2004 Dec; 14(24):2302-8. PubMed ID: 15620660
[TBL] [Abstract][Full Text] [Related]
3. The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression.
Ohtani N; Yamakoshi K; Takahashi A; Hara E
J Med Invest; 2004 Aug; 51(3-4):146-53. PubMed ID: 15460900
[TBL] [Abstract][Full Text] [Related]
4. Different telomere damage signaling pathways in human and mouse cells.
Smogorzewska A; de Lange T
EMBO J; 2002 Aug; 21(16):4338-48. PubMed ID: 12169636
[TBL] [Abstract][Full Text] [Related]
5. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a).
Herbig U; Jobling WA; Chen BP; Chen DJ; Sedivy JM
Mol Cell; 2004 May; 14(4):501-13. PubMed ID: 15149599
[TBL] [Abstract][Full Text] [Related]
6. p16(INK4a) protects against dysfunctional telomere-induced ATR-dependent DNA damage responses.
Wang Y; Sharpless N; Chang S
J Clin Invest; 2013 Oct; 123(10):4489-501. PubMed ID: 24091330
[TBL] [Abstract][Full Text] [Related]
7. Genes involved in the control of cellular proliferative potential.
Reddel RR
Ann N Y Acad Sci; 1998 Nov; 854():8-19. PubMed ID: 9928415
[TBL] [Abstract][Full Text] [Related]
8. DNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions.
Fordyce C; Fessenden T; Pickering C; Jung J; Singla V; Berman H; Tlsty T
Cancer Prev Res (Phila); 2010 Feb; 3(2):190-201. PubMed ID: 20028875
[TBL] [Abstract][Full Text] [Related]
9. Centrosome aberrations in human mammary epithelial cells driven by cooperative interactions between p16INK4a deficiency and telomere-dependent genotoxic stress.
Domínguez D; Feijoo P; Bernal A; Ercilla A; Agell N; Genescà A; Tusell L
Oncotarget; 2015 Sep; 6(29):28238-56. PubMed ID: 26318587
[TBL] [Abstract][Full Text] [Related]
10. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion.
Celli GB; de Lange T
Nat Cell Biol; 2005 Jul; 7(7):712-8. PubMed ID: 15968270
[TBL] [Abstract][Full Text] [Related]
11. Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres.
Roake CM; Artandi SE
Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28289249
[TBL] [Abstract][Full Text] [Related]
12. Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms.
Davis T; Singhrao SK; Wyllie FS; Haughton MF; Smith PJ; Wiltshire M; Wynford-Thomas D; Jones CJ; Faragher RG; Kipling D
J Cell Sci; 2003 Apr; 116(Pt 7):1349-57. PubMed ID: 12615976
[TBL] [Abstract][Full Text] [Related]
13. Bypass of telomere-dependent replicative senescence (M1) upon overexpression of Cdk4 in normal human epithelial cells.
Ramirez RD; Herbert BS; Vaughan MB; Zou Y; Gandia K; Morales CP; Wright WE; Shay JW
Oncogene; 2003 Jan; 22(3):433-44. PubMed ID: 12545164
[TBL] [Abstract][Full Text] [Related]
14. Cell death during crisis is mediated by mitotic telomere deprotection.
Hayashi MT; Cesare AJ; Rivera T; Karlseder J
Nature; 2015 Jun; 522(7557):492-6. PubMed ID: 26108857
[TBL] [Abstract][Full Text] [Related]
15. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1.
Denchi EL; de Lange T
Nature; 2007 Aug; 448(7157):1068-71. PubMed ID: 17687332
[TBL] [Abstract][Full Text] [Related]
16. Telomeres-structure, function, and regulation.
Lu W; Zhang Y; Liu D; Songyang Z; Wan M
Exp Cell Res; 2013 Jan; 319(2):133-41. PubMed ID: 23006819
[TBL] [Abstract][Full Text] [Related]
17. Senescence and immortalization of human cells.
Duncan EL; Wadhwa R; Kaul SC
Biogerontology; 2000; 1(2):103-21. PubMed ID: 11707927
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle arrest in replicative senescence is not an immediate consequence of telomere dysfunction.
Nassrally MS; Lau A; Wise K; John N; Kotecha S; Lee KL; Brooks RF
Mech Ageing Dev; 2019 Apr; 179():11-22. PubMed ID: 30710559
[TBL] [Abstract][Full Text] [Related]
19. Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase.
Vaziri H; Benchimol S
Oncogene; 1999 Dec; 18(53):7676-80. PubMed ID: 10618707
[TBL] [Abstract][Full Text] [Related]
20. Regulation of growth arrest in senescence: telomere damage is not the end of the story.
Herbig U; Sedivy JM
Mech Ageing Dev; 2006 Jan; 127(1):16-24. PubMed ID: 16229875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
